Monsanto's EPA-Manipulating Tactics Revealed in $289 Million Case, Rolling Stone - August 2018: click here to read the full article.
Have you or a loved one used or been exposed to Roundup Weed Killer and been diagnosed with non-Hodgkin's Lymphoma? You or your family may qualify for compensation. Click the button to the right to learn more and get in touch with our attorneys today.
Round Up Cancer Risks
In early 2015, the World Health Organization’s (WHO) International Agency for Research on cancer (IARC) warned that the weed killer Roundup, manufactured by Monsanto, was a probable carcinogen. As a result of Monsanto’s failure to adequately warn about the potential cancer risk, financial compensation may be available through a Roundup lawsuit.
At this time LPT & Associates PLLC ONLY investigating cases where frequent users of “RoundUp” were diagnosed with non-Hodgkin’s lymphoma, which may include: multiple myeloma, diffuse B-cell lymphoma, lymphocytic lymphoma, follicullar/hairy-cell leukemia, chronic lymphocytic leukemia (CLL), mantle-cell, cutaneous T-cell, and small lymphocytic lymphoma (SLL).
For years concerns have existed about a risk of cancer from herbicides and weed killers, specifically non-Hodgkin’s Lymphoma. However, recent reports have suggested that many cancers suffered by agricultural workers may have been caused by side effects of Roundup exposure. In early 2015, the World Health Organization’s (WHO) International Agency for Research on cancer (IARC) warned that the weed killer Roundup was a probable carcinogen.
Recent research has shown potential links to cancer from the use of or exposure to Roundup Weed Killer’s active ingredient glyphosate. A recent study into the effects of glyphosate indicates a potential link with several major issues, including cancer and liver and kidney damage. Severe cases of liver or kidney damage can disrupt the body’s endocrine system, which regulates hormones. This disruption increases the risk of non-Hodgkin lymphoma. Due to limited regulation of or research on glyphosate in the U.S., data is limited. However, a 2003 American study of more than 3,400 farmworkers from the Midwest found higher rates of non-Hodgkin lymphoma associated with glyphosate. Additionally, persons who have been exposed to Roundup have traces of the herbicide in both their blood and urine, according to research.
Based on analysis of several global studies, the IARC has classified Roundup as a "probable human carcinogen". The primary Roundup cancer risk is for gardeners, landscape workers, farmers and others who work with the substance. Roundup lymphoma or cancer can result from as few as 8 hours of exposure, according to one study. Roundup that has been absorbed into food crops is not thought to pose a risk for cancer at this time.
Several studies conducted around the world have contributed to our understanding of the Roundup lymphoma risk. Today we know that anyone who has used the common herbicide may develop lymphoma. Those who use the glyphosate herbicide directly are most at risk, but research shows that persons living in areas where the product is often used also show signs of developing lymphoma or other cancers. Chromosomal DNA changes have been detected in the general public which indicate individuals exposed to environmental glyphosate may also be at risk of developing cancer from Roundup.
Monsanto Denies Round Up Cancer Risk
At this time, Monsanto continues to assert that the Roundup cancer risk is not real. Based on the generous donations Monsanto gives to many important causes, many Americans find it difficult to believe the company would put human lives at risk. However, over the decades, Monsanto officials have been the subject of FDA and DOJ investigations and litigation for involvement in fraudulent scientific studies which reportedly have produced falsified evidence disproving the link between Roundup and cancer.
In the 1970s, Monsanto hired Industrial Bio-Test Laboratories to conduct Roundup cancer research. A 1976 federal investigation by the FDA determined the research company was guilty of "routine falsification of data" in its Roundup testing. Three top executives of IBT Laboratories were convicted of fraud in 1983.
In 1991, Monsanto worked with Craven Laboratories to again examine the safety of Roundup and the validity of Roundup cancer claims. A later Department of Justice investigation revealed Craven used falsified data in its research and produced results which supported Monsanto's assertions. The company's owner and several employees were eventually convicted of fraudulent lab practices in their testing related to Roundup and cancer risks.
In 1996, the New York Attorney General's office brought fraud claims against Monsanto, alleging false advertising of Roundup. Monsanto was forced to cease and desist its advertising claims in the state of New York; the company can no longer advertise Roundup as safe for human use. However, in most other states, Monsanto is still free to advertise Roundup as it wishes.